C12N 2795/18122
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2795/18122 (New viral proteins or individual genes, new structural or functional aspects of) appears on 59 US grants and 102 published applications in this corpus.
Search patents in C12N- Granted patents
- 59
- Published applications
- 102
- Assignees
- 52
- Inventors
- 214
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 5 |
| 2004 | 0 | 3 |
| 2005 | 0 | 1 |
| 2006 | 5 | 4 |
| 2007 | 1 | 6 |
| 2008 | 1 | 1 |
| 2009 | 2 | 1 |
| 2010 | 2 | 5 |
| 2011 | 0 | 4 |
| 2012 | 0 | 3 |
| 2013 | 2 | 3 |
| 2014 | 1 | 2 |
| 2015 | 1 | 3 |
| 2016 | 1 | 5 |
| 2017 | 1 | 0 |
| 2018 | 3 | 5 |
| 2019 | 2 | 2 |
| 2020 | 2 | 5 |
| 2021 | 1 | 7 |
| 2022 | 2 | 9 |
| 2023 | 5 | 4 |
| 2024 | 7 | 10 |
| 2025 | 1 | 7 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for microbial delivery of double stranded RNA28 Jul 2026US 12,690,596 B2Rnaissance AG LLC
- Mutant myocilin disease model and uses thereof24 Mar 2026US 12,582,104 B2Regeneron Pharmaceuticals, Inc.
- Cells for enhanced production of adeno-associated virus17 Mar 2026US 12,577,539 B2The Regents of the University of California
- Lentiviral-based vectors and related systems and methods for eukaryotic gene editing26 Aug 2025US 12,398,182 B2Wake Forest University Health Sciences
- Malaria immunogen and methods for using same10 Dec 2024US 12,161,710 B2The Johns Hopkins University
- Methods and compositions for microbial delivery of double stranded rna8 Oct 2026US 2026/0305618 A1Rnaissance AG LLC
- Compositions and methods of genome editing23 Jul 2026US 2026/0209730 A1Epigenic Therapeutics Pte. Ltd.
- Improved system for producing rna-packaged aav particles9 Jul 2026US 2026/0193673 A1Huidagene Therapeutics (Singapore) Pte. Ltd.
- Compositions and methods for precise editing of human dystrophin9 Apr 2026US 2026/0097134 A1Mammoth Biosciences, Inc.
- Delivery of heterologous proteins26 Feb 2026US 2026/0055146 A1Sana Biotechnology, Inc.
Most cited
By later US patents
- Autocatalytic replication of recombinant RNA181US 4,786,600 AThe Trustees of Columbia University in the City of New York · 1988
- Ribonuclease resistant RNA preparation and utilization80US 5,939,262 AAmbion, Inc. · 1999
- Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use44US 7,517,520 B2Cytos Biotechnology AG · 2009
- Visualization of RNA in living cells43US 6,586,240 B1Albert Einstein College of Medicine of Yeshiva University · 2003
- Method of preparing polypeptides in cell-free translation system38US 5,478,730 AInstitute of Protein Research · 1995